Ivabradine

Ivabradine Impurities

Ivabradine is a selective If channel inhibitor that is generally used in the treatment of chronic stable angina and heart failure. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. These impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways of Ivabradine API involve oxidative breakdown of the benzazepinone moiety, hydrolytic cleavage of amide bonds, and rearrangement of substituents within the heteroaromatic scaffold. It should be noted that these impurities may affect the potency, stability, and safety of the Ivabradine drug products. Thus, all the Ivabradine impurities should be structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Ivabradine EP Impurities

We provide the pharmacopeial and non-pharmacopeial Ivabradine impurity compounds that are available in compliance with European Pharmacopoeia (EP) specifications. These standards can support analytical method development, impurity profiling, and long-term stability studies. Therefore, EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Ivabradine Related Compounds

Structurally related compounds and synthetic analogs of Ivabradine are necessary for impurity identification, toxicological qualification, and regulatory submission. The Ivabradine related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. Hence, they are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Ivabradine Impurity Reference Standards

We also provide the Ivabradine impurity reference standards along with validated analytical data. This includes purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. Thus, EP/USP traceable products are available upon request. The synthesized products are routinely re-tested to ensure consistency and reliability.